Tuesday, May 10, 2011

Geron spinal cord stem cell trial enrolls 2nd patient

Geron Corp., which last week won a $25 million loan from California’s stem cell research funding agency for a spinal cord injury trial, has recruited the second patient into that study.
The first Food and Drug Administration-approved trial using embryonic stem cells in humans enrolled its second patient, researchers at Northwestern Memorial Hospital and the Rehabilitation Institute of Chicago reportedly said Tuesday.

No comments:

Post a Comment